XPO1 Inhibition enhances sensitivity to platinum-based chemotherapy in germinal-center B-cell-like-DLBCL cells

XPO1 inhibition enhances platinum-induced cytotoxicity in GCB-DLBCL, supporting clinical evaluation of XPO1i-platinum combinations as salvage therapy.

Authors

Institutions

Publication Details

Journal
Hematology
Published
2026-02-03
DOI
https://doi.org/10.1080/16078454.2026.2619209
Primary Topic
Cell death mechanisms and regulation
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

XPO1 Inhibition enhances sensitivity to platinum-based chemotherapy in germinal-center B-cell-like-DLBCL cells

Qing Su, Xiaolei Wei, Yongqiang Wei, Ru Feng
Hematology
Cell death mechanisms and regulation
article

XPO1 Inhibition enhances sensitivity to platinum-based chemotherapy in germinal-center B-cell-like-DLBCL cells

Qing Su, Xiaolei Wei, Yongqiang Wei, Ru Feng
article en

Abstract

XPO1 inhibition enhances platinum-induced cytotoxicity in GCB-DLBCL, supporting clinical evaluation of XPO1i-platinum combinations as salvage therapy.

HematologyVol. 31(1)
Southern Medical University (CN)
Responsible consumption and production
Openalex Percentile: Top 68%
Cell death mechanisms and regulation
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

XPO1 Inhibition enhances sensitivity to platinum-based chemotherapy in germinal-center B-cell-like-DLBCL cells — Qing Su, Xiaolei Wei, et al. · Hematology (2026) | TGRS Research Map | TGRS